Pharming Group
PHAR
11 hedge funds and large institutions have $2.48M invested in Pharming Group in 2025 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
189% more capital invested
Capital invested by funds: $857K → $2.48M (+$1.62M)
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
22% more funds holding
Funds holding: 9 → 11 (+2)
0.12% more ownership
Funds ownership: 0.09% → 0.2% (+0.12%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
+$450K |
| 2 |
Millennium Management
New York
|
+$321K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$278K |
| 4 |
Morgan Stanley
New York
|
+$52.6K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$11K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SBCM
Silverberg Bernstein Capital Management
Armonk,
New York
|
-$25.2K |
| 2 |
EWA
EverSource Wealth Advisors
Birmingham,
Alabama
|
-$7.44K |
| 3 |
GRP
Global Retirement Partners
San Rafael,
California
|
-$334 |
| 4 |
SS
SBI Securities
Tokyo,
Japan
|
-$29 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SBCM
1
Silverberg Bernstein Capital Management
Armonk,
New York
| $893K | -$25.2K | -1,600 | -3% |
|
|
NA
2
NewEdge Advisors
New Orleans,
Louisiana
| $510K | +$450K | +28,615 | +11,310% |
|
|
3
Millennium Management
New York
| $360K | +$321K | +20,385 | New |
|
|
4
Citadel Advisors
Miami,
Florida
| $313K | +$278K | +17,690 | New |
|
|
SP
5
SmartHarvest Portfolios
Poulsbo,
Washington
| $224K | +$200K | +12,687 | New |
|
|
6
Morgan Stanley
New York
| $136K | +$52.6K | +3,345 | +77% |
|
|
EWA
7
EverSource Wealth Advisors
Birmingham,
Alabama
| $16K | -$7.44K | -473 | -34% |
|
|
NSG
8
Nalls Sherbakoff Group
Knoxville,
Tennessee
| $15.4K | – | – | – |
|
|
9
BNP Paribas Financial Markets
Paris,
France
| $14.1K | +$11K | +700 | +700% |
|
10
UBS Group
Zurich,
Switzerland
| $18 | +$16 | +1 | New |
|
|
GRP
11
Global Retirement Partners
San Rafael,
California
| – | -$334 | -23 | Closed |
|
|
SS
12
SBI Securities
Tokyo,
Japan
| – | -$29 | -2 | Closed |
|
PHAR Hedge Fund Activity: Q4 2025 in Review
11 of the 8,227 institutional investors tracked by Wall St. Rank reported a position in Pharming Group (PHAR) for Q4 2025, worth a combined $2.48M — up 189% from $857K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new PHAR positions and 2 closed out — a net gain of 2 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was NewEdge Advisors, adding an estimated $450K. The largest seller was Silverberg Bernstein Capital Management, cutting an estimated $25.2K.
- 11 institutional investors held Pharming Group (PHAR) as of Q4 2025, up from 9 in Q3 2025.
- Funds reported $2.48M of Pharming Group stock for Q4 2025, up 189% quarter-over-quarter.
- 4 funds opened new Pharming Group positions in Q4 2025 and 2 closed out, a net change of +2 holders.
- The largest Pharming Group buyer in Q4 2025 was NewEdge Advisors, an estimated $450K added.
- The largest Pharming Group seller in Q4 2025 was Silverberg Bernstein Capital Management, an estimated $25.2K sold.
Based on aggregated 13F filings for Q4 2025.